Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma
Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma
复制标题
DOI:
10.1111/j.1365-2265.2009.03537.x
复制
发表时间:
2009-10-01
影响因子:
3.2
通讯作者:
Shong, Young Kee
中科院分区:
文献类型:
--
作者:
Kim, Eui Young;Kim, Won Gu;Shong, Young Kee
P>ObjectiveThe effect of coexistent chronic lymphocytic thyroiditis (CLT) on prognosis in papillary thyroid carcinoma (PTC) patients remains controversial. We evaluated the influence of coexistent CLT on prognostic outcome and the association of coexistent CLT with clinicopathological parameters.DesignA retrospective study with a median follow-up of 70 months.Patients and measurementsPatients with PTC who underwent total thyroidectomy followed by I-131 remnant ablation between 1995 and 2003 at Asan Medical Center, Seoul, Korea were enrolled. CLT was diagnosed histopathologically.ResultsAmong 1441 patients, 214 (14 center dot 9%) had coexistent CLT. A greater female preponderance was noted in the patients with CLT compared with those without CLT (P < 0 center dot 01). Mean tumour size in the patients with CLT was smaller than that in patients without CLT (2 center dot 0 +/- 1 center dot 2 vs. 2 center dot 2 +/- 1 center dot 4 cm; P = 0 center dot 02). One hundred and fifty-one (12 center dot 3%) patients without CLT had recurrence, whereas 14 (7 center dot 1%) patients with CLT had recurrence during the follow-up period (P = 0 center dot 016). In patients with cervical lymph node metastases, those with coexistent CLT showed a significantly lower recurrence rate than those without CLT (P = 0 center dot 012). However, this association was lost on multivariate analysis adjusting for other clinicopathological predictors for recurrence.ConclusionsIn this study, CLT was commonly associated with PTC and was associated with smaller size of the primary tumour at presentation. CLT was also associated with a reduced risk of recurrence during follow-up, although this was not significant after adjustment for other prognostic factors.